Brief: Xbrane Biopharma Signs License Agreement In China
Feb 6 (Reuters) - XBRANE BIOPHARMA AB XBRANE.ST :
* REG-XBRANE BIOPHARMA SIGNS LICENSE AGREEMENT WITH CR
PHARMA FOR
SPHEROTIDE IN CHINA
* WILL RECEIVE A LICENSE FEE IN HIGH SINGLE DIGIT MILLION
USD
RANGE
Source text for Eikon: ID:nGNE6KTrpC
Further company coverage: XBRANE.ST
(Gdynia Newsroom)
((gdynia.newsroom@thomsonreuters.com; +48 58 772 0920;))